Giacomo Tampella

Giacomo Tampella, Ph.D., is a Principal Scientist at Pfizer, following a tenure as Senior Scientist at Seagen, where involvement included ADC cancer immunotherapy research. Prior roles include Senior Scientist at Neoleukin Therapeutics, focusing on Treg agonist programs, and Research Scientist IV supervisor at Seattle Children's, contributing to CAR-T clinical trials for B cell malignancies. Academic training includes a Ph.D. in Immunology from Università degli Studi di Trieste and significant research experience at renowned institutions, including University College London and University of Brescia, emphasizing their expertise in immunology and molecular genetics.